Results per Page:
Dr. Soheil Meshinchi, a leading expert in acute myeloid leukemia, named Dylan Burke Endowed Chair in Immunotherapy
Meshinchi’s research training the body to fight cancer is expanding from blood cancers to solid tumors
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
February 27, 2026
Stealing a base from cancer: precision editing for safer immunotherapy
From the Kiem Lab, Translational Science and Therapeutics Division
Gratitude for life-saving care at Fred Hutch leads to endowed chair
Dr. Madhav Dhodapkar is the recipient of the Milton B. Rubin Family Endowed Chair
Age-dependent genetic alterations in AML patients
From the Meshinchi Lab, Translational Science & Therapeutics Division
American Society of Clinical Oncology honors Fred Hutch and UW hematology-oncology fellows
Five early-career researchers to each receive $50,000 toward innovative cancer research projects
Giving that feels ‘beyond meaningful’
The Steinberg family honors the memory of loved ones by celebrating and supporting a profession that takes caring to another level
Your ZIP Code Can Help Inform your Survival Chances: Access Gaps in AML Treatment
From the Sorror group, Clinical Research Division
Cracking the sparkle code
Fred Hutch cancer biologist wins V Foundation Scholar Award to explore role of protein sugaring in leukemia tumors that survive chemotherapy
Location, location, location: where is key for CAR T-cell therapy
From the Walter lab, Translational Science and Therapeutics Division
Boosting the effectiveness of CAR T-cell therapies against AML
Dr. Erik Kimble wins award from the American Society of Gene & Cell Therapy
When more isn’t more for AML patients undergoing hematopoietic stem cell transplant
From the Walter and Storb Labs, Translational Sciences and Therapeutics Division
Flipping out to develop an intracellular protein-targeting CAR T cell therapy to treat AML
From the Meshinchi Lab, Clinical Research and Translational Science and Therapeutics Divisions.
Project Stella enables novel pediatric AML immunotherapies, potential cure
Fred Hutch's Dr. Soheil Meshinchi's lab identifies potential drug while also developing immunotherapy thanks to fundraising